Spatially encoded biological assays
The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.
1. A method of determining presence or abundance or both of a target biological molecule at a region of interest in a tissue sample, comprising:
(a) delivering a plurality of probes to a tissue sample, wherein a probe of the plurality of probes comprises a capture agent that specifically binds a target biological molecule of the tissue sample, wherein the capture agent is conjugated to an oligonucleotide;
(b) separating the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at a region of interest in the tissue sample from a plurality of probes not specifically bound to a target biological molecule at the region of interest in the tissue sample;
(c) removing the oligonucleotide from the region of interest and determining a sequence of all or a portion of the oligonucleotide via hybridization of a probe comprising (i) a sequence that is 100% complementary to a portion of the oligonucleotide and (ii) a label; and
(d) using the determined sequence of the oligonucleotide to determine presence or abundance or both of the target biological molecule at the region of interest in the tissue sample.
2. The method of claim 1 , wherein the method further comprises obtaining an image of the tissue sample.
3. The method of claim 1 , wherein step (b) comprises washing the tissue sample to separate the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample from the plurality of probes not specifically bound to the target biological molecule at the region of interest in the tissue sample.
4. The method of claim 1 , wherein step (c) comprises detecting the label.
5. The method of claim 1 , wherein the label is a fluorophore.
6. The method of claim 5 , wherein step (c) comprises detecting the fluorophore.
7. The method of claim 1 , wherein the target biological molecule comprises a nucleic add.
8. The method of claim 7 , wherein the nucleic add is mRNA.
9. The method of claim 1 , wherein the target biological molecule comprises a protein.
10. The method of claim 1 , wherein the capture agent is a small molecule, an aptamer, or a substrate for an enzyme.
11. The method of claim 1 , wherein the capture agent is an antibody.
12. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine the presence of the target biological molecule at the region of interest in the tissue sample.
13. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine the abundance of the target biological molecule at the region of interest in the tissue sample.
14. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine associate the presence and abundance of the target biological molecule at the region of interest in the tissue sample.
15. The method of claim 1 , wherein two or more probes of the plurality of probes specifically bind to unique target biological molecules of the tissue sample.
16. The method of claim 15 , wherein step (c) comprises determining all or a portion of the sequence of the oligonucleotide of the two or more probes in parallel.
17. The method of claim 15 , wherein the two or more probes is at least one thousand probes.
18. The method of claim 1 , wherein the plurality of probes is delivered to multiple regions of interest in the tissue sample.
19. The method of claim 18 , wherein the method further comprises detecting differential expression of the target biological molecule in one or more of the multiple regions of interest of the tissue sample.
20. The method of claim 19 , wherein one or more of the multiple regions of interest are determined by histological features of the tissue sample.
21. The method of claim 19 , wherein the differential expression of the target biological molecule is associated with a biological structure or cell type.
22. The method of claim 19 , wherein the differential expression of the target biological molecule comprises gene or protein expression.
23. The method of claim 1 , wherein the tissue sample is a tissue section.
24. The method of claim 23 , wherein the tissue section comprises a fresh-frozen or formalin-fixed paraffin embedded (FFPE) tissue sample.
25. The method of claim 1 , wherein the capture agent comprises a nucleic acid and the target biological molecule comprises an mRNA.
26. The method of claim 1 , wherein the capture agent comprises an antibody and the target biological molecule comprises a protein.
27. The method of claim 1 , wherein the method further comprises obtaining an image of the tissue sample to identify the region of interest in the tissue sample.
28. The method of claim 1 , wherein removing the oligonucleotide from the region of interest comprises decoupling.